3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Breast Neoplasms
5
Colorectal Neoplasms
4
Hematologic Neoplasms
3
Prostatic Neoplasms
2
Motor Activity
2
Lung Neoplasms
2
Hodgkin Disease
2
Hematopoietic and Lymphoid System Neoplasm
2
Carcinoma, Non-Small-Cell Lung
2
Trastuzumab Cardiotoxicity
1
Stress Disorders, Post-Traumatic
1
Sleep Wake Disorders
1
Sedentary Behavior
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity
1
Neoplasms
1
Neoplasm Metastasis
1
Myocardial Fibrosis
1
Multiple Endocrine Neoplasia Type 1
1
Lymphoma, Follicular
1
Insulin Resistance
1
Hereditary Breast and Ovarian Cancer Syndrome
1
Heart Diseases
1
Head and Neck Neoplasms
1
Gastrointestinal Diseases
1
Fatigue
1
Esophageal Neoplasms
1
Dyslipidemias
1
Depression
1
Interventions
Fluorouracil
128
Leucovorin
120
Oxaliplatin
101
Irinotecan
89
Bevacizumab
55
Cetuximab
44
Capecitabine
40
Folfox protocol
29
Panitumumab
22
Colonoscopy
17
Chemotherapy, Adjuvant
16
Floxuridine
15
Early Intervention, Educational
15
Erlotinib Hydrochloride
13
Surveys and Questionnaires
11
IFL protocol
11
Counseling
11
Celecoxib
11
Immunohistochemistry
10
Gemcitabine
10
Psychiatric Rehabilitation
9
Methods
8
Magnetic Resonance Spectroscopy
8
Gene Expression Profiling
8
Exercise
8
Dexamethasone
8
sargramostim
7
Sorafenib
7
Radiotherapy
7
Nivolumab
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Colonic Neoplasms
×
Exercise Test
×
Clear all
NCT00819208
2026-04-24
CHALLENGE
Canadian Cancer Trials Group
Phase NA
Completed
889 enrolled
9 charts